Upgrading an existing pharmaceutical manufacturing facility is a multi-stage project. It may involve changing production equipment, improving clean rooms, modernising utilities, expanding testing capacity and strengthening environmental-control systems.
If these activities are started without a clear sequence, manufacturers may face inconsistent quotations, delayed installation, incomplete records and difficulty connecting expenditure with the intended compliance objective.
The RPTUAS Scheme offers financial assistance to eligible existing pharmaceutical manufacturing units undertaking approved technology-upgradation activities. RPTUAS stands for Revamped Pharmaceutical Technology Upgradation Assistance Scheme and focuses on improvements connected with Revised Schedule M and WHO-GMP requirements.
A phase-wise approach can help manufacturers plan the project more effectively. It creates a clear path from initial eligibility assessment to implementation, compliance evidence and potential assistance disbursement.
Why Should a Pharma Upgrade Be Divided Into Phases?
A pharmaceutical facility contains several connected systems. Production machinery may depend on HVAC, water, steam, clean-room conditions, laboratory testing and waste-management infrastructure.
Purchasing one machine without reviewing these connected systems may not solve the underlying facility gap. It may also result in equipment being delivered before the installation area or required utility is ready.
Dividing the project into phases helps the business:
- Identify critical improvements first
- Coordinate machinery with supporting utilities
- Prepare a realistic implementation schedule
- Connect each activity with its intended purpose
- Maintain separate expenditure records
- Track installation and compliance evidence
- Reduce production disruption
- Prepare documents for application and disbursement stages
Before beginning expenditure, manufacturers can review available funding support for pharma plant technology upgrades to understand basic eligibility, assistance slabs and covered activities.
Complete an Initial Eligibility Screening
The first phase should determine whether the unit and project appear to meet the basic requirements of the RPTUAS Scheme.
The manufacturer should verify:
- Whether the pharmaceutical unit is existing and operational
- Whether it manufactures formulations, APIs or eligible raw materials
- Whether a valid manufacturing licence is available
- Whether average turnover for the previous three years is below ₹500 crore
- Whether the proposed expenditure relates to technology or compliance upgradation
- Whether investment falls within the applicable period
- Whether similar assistance has already been received for the same investment
A trader without eligible pharmaceutical manufacturing activity should not assume qualification. Similarly, a new unit that has not started operations should verify whether it meets the existing-unit requirement.
This screening prevents the business from spending time and money on a project that does not satisfy the basic conditions.
Conduct a Facility-Wide Gap Assessment
After the initial eligibility check, the manufacturer should examine the present condition of the facility.
The assessment should cover more than production machinery. It may include:
Manufacturing Areas
Review whether the existing layout, production flow and equipment support the intended process and product requirements.
Clean-Room Conditions
Check air filtration, pressure controls, entry arrangements, surface conditions and other contamination-control measures.
HVAC and Utilities
Assess HVAC, purified-water systems, steam generation, compressed air, power backup and other supporting utilities.
Quality-Control Systems
Review laboratory equipment, stability chambers, testing arrangements and record-maintenance systems.
Environmental Facilities
Examine effluent treatment, waste management and pollution-control arrangements.
Documentation Practices
Check whether equipment, testing, monitoring and maintenance activities are supported by appropriate records.
The output of this phase should be a structured gap analysis explaining the existing condition, identified weakness, required improvement and expected result.
Convert Gaps Into Upgrade Activities
A gap analysis becomes useful only when every major issue is converted into a practical project activity.
For example:
| Identified gap | Proposed activity |
|---|---|
| Inadequate environmental control | Upgrade HVAC and pressure-monitoring systems |
| Limited stability-testing capacity | Install an eligible stability chamber |
| Weak waste-treatment arrangement | Improve the effluent-treatment system |
| Outdated production process | Procure suitable production equipment |
| Insufficient water-system capacity | Upgrade the purified-water system |
| Limited QC testing capability | Add required laboratory instruments |
Each proposed activity should have a technical purpose. Avoid adding equipment merely because it is available under a supplier package or appears on a general eligibility list.
The manufacturer should also identify dependencies. A new production machine may require changes to power, HVAC, water, layout or clean-room conditions before it can be installed.
Prioritise Critical and Supporting Activities
All upgrades may not need to begin at the same time. The manufacturer should classify proposed activities according to priority.
Critical Compliance Activities
These are improvements directly connected with significant facility or regulatory gaps.
Production-Readiness Activities
These include machinery and systems required to improve or maintain the manufacturing process.
Supporting Infrastructure
These may include utilities, laboratory arrangements and environmental systems that support the main production activity.
Professional and Certification Activities
These may include eligible consultation, audit or certification expenses connected with the approved project.
A priority matrix can help the management team decide which activities must be completed first and which can follow after the main facility work.
Prepare Technical Specifications and Quotations
After the project scope is approved internally, the unit should obtain detailed quotations from suitable suppliers.
Each quotation should preferably mention:
- Supplier’s legal name and address
- Equipment or system description
- Model and technical specifications
- Capacity
- Quantity
- Basic price
- Applicable taxes
- Freight terms
- Installation responsibilities
- Payment schedule
- Delivery period
- Quotation validity
Specifications should reflect the actual requirement identified during the gap assessment. An oversized, unrelated or poorly described machine may be difficult to justify.
The same equipment name and model should be used in the gap report, project report, quotation, purchase order, invoice and fixed-asset register.
Create an Eligible-Cost Register
The complete cost of a pharma plant upgrade may contain both covered and excluded expenditure. These amounts should be separated before estimating assistance.
Potentially relevant categories identified on the GetMyCA pages include:
- HVAC, water and steam utilities
- Clean-room facilities
- Quality-control equipment
- Stability chambers
- Effluent treatment and waste management
- Production machinery and tools
- Testing of finished products, raw materials and packaging
- Certain consultation or certification expenses
The service page identifies the following as generally not covered:
- Land or building
- Vehicles
- Old or used equipment
- Working capital
- Salaries
- General training expenditure
A separate cost register should show the description, supplier, quotation value, purpose, applicable tax, payment terms and preliminary eligibility status of every item.
Plan the Funding Structure
A bank loan is not stated as compulsory under the current RPTUAS structure. The manufacturer may use its own funds, a bank loan or a combination of both, subject to applicable conditions.
The funding plan should show:
- Total project cost
- Potentially eligible investment
- Excluded expenditure
- Promoter contribution
- Term loan, if applicable
- Supplier-payment schedule
- Taxes and installation requirements
- Estimated assistance, subject to approval
- Balance amount to be funded independently
Assistance is linked with approved expenditure and compliance milestones. The business should therefore maintain sufficient financial capacity to continue the project without treating the estimated amount as immediately available or guaranteed.
Build the Application Document File
A complete project file may contain:
Business Records
- Incorporation or constitution documents
- PAN
- GST registration
- Udyam registration, where applicable
- Valid pharmaceutical manufacturing licence
Technical Records
- Gap analysis
- Project report
- Equipment specifications
- Supplier quotations
- Existing facility photographs
- Proposed implementation schedule
Financial Records
- Audited financial statements for the previous three years
- Bank statements
- Cost estimates
- Proposed funding details
- Investment records
- CA-certified expenditure, where required
Manufacturers can also review this pharmaceutical manufacturing subsidy guidance for details about covered activities and turnover-based assistance.
Follow the Correct Purchase and Payment Sequence
Once the project moves into implementation, every purchase should follow the approved scope and documentation plan.
The purchase order should match the supplier quotation. The final invoice should use the same machinery description, model and quantity.
Payments should be made through the appropriate business bank account and linked with:
- Purchase order
- Supplier invoice
- Bank transaction
- Delivery document
- Installation record
- Accounting entry
If payment is made in multiple instalments, each amount should be separately mapped to the relevant supplier and invoice.
A project tracker should record quotation, order, invoice, payment, delivery and installation dates.
Monitor Installation and Commissioning
Delivery of machinery does not complete the upgradation project. The unit should document installation, commissioning and integration with the manufacturing facility.
Evidence may include:
- Delivery records
- Installation reports
- Equipment photographs
- Commissioning certificates
- Utility-connection records
- Calibration or validation documents
- Updated layout or facility records
- Fixed-asset entries
Any change in the approved machinery or project scope should be properly reviewed and documented. Informal substitutions can create differences between the application and actual implementation.
Prepare for Compliance Milestones
The current RPTUAS service page describes financial assistance as being released in two instalments connected with compliance milestones.
The first instalment is linked with Revised Schedule M compliance, while the second instalment is linked with WHO-GMP certification, subject to verification and applicable scheme conditions.
This means the project team must preserve technical, financial and compliance records even after installation.
The manufacturer should organise:
- Expenditure statements
- Bank-payment evidence
- Installation records
- Compliance certificates
- Audit documents
- Facility photographs
- Testing records
- Applicable declarations
Project approval and assistance disbursement are separate stages. Completion of expenditure does not automatically result in fund release.
Conduct a Final Internal Review
Before submitting compliance or disbursement documents, the manufacturer should check whether:
- The manufacturing licence remains valid
- Turnover matches audited records
- All machinery matches approved specifications
- Eligible and excluded expenses remain separated
- Invoices match purchase orders
- Payments are traceable through bank records
- Assets appear in the fixed-asset register
- Installation evidence is available
- Compliance records support the required milestone
- No duplicate subsidy is being claimed for the same investment
This review can identify mismatches before the file reaches the formal verification stage.
Conclusion
A phase-wise roadmap can help existing pharmaceutical manufacturers manage a complex technology-upgradation project under the RPTUAS Scheme.
The process should begin with eligibility screening and a facility-wide gap assessment. Manufacturers can then convert identified gaps into technical activities, obtain detailed quotations, separate covered costs and prepare an appropriate funding plan.
During implementation, purchase orders, invoices, payments, delivery records and installation evidence should remain consistent. After installation, the business must continue maintaining documents for Revised Schedule M and WHO-GMP-related compliance milestones.
